Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2017

Jan 17, 2018

SELL
$59.94 - $65.35 $215,784 - $235,259
-3,600 Closed
0 $0
Q3 2017

Oct 10, 2017

BUY
$55.23 - $63.74 $198,828 - $229,464
3,600
3,600 $229,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $115B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Lawson Kroeker Investment Management Inc Portfolio

Follow Lawson Kroeker Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lawson Kroeker Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Lawson Kroeker Investment Management Inc with notifications on news.